The Strategic Role of Sino-U.S. Bilateral Investments in China’s Advance in the Field of Biotechnologies

Recognizing from a very early stage the capacity of advanced technologies (and of biotechnologies in particular) to fundamentally change the economy, the geopolitics, and the society of the 21st century, Chinese authorities placed the development of the biotechnology sector among the top national pr...

Full description

Saved in:
Bibliographic Details
Main Author: ANA-CRISTINA BÂLGĂR
Format: Article
Language:English
Published: Nicolae Titulescu University 2022-06-01
Series:Global Economic Observer
Subjects:
Online Access:http://www.globeco.ro/wp-content/uploads/vol/split/vol_10_no_1/geo_2022_vol10_no1_art_005.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Recognizing from a very early stage the capacity of advanced technologies (and of biotechnologies in particular) to fundamentally change the economy, the geopolitics, and the society of the 21st century, Chinese authorities placed the development of the biotechnology sector among the top national priorities and, as a result, adopted political strategies and programmes meant to help achieving this goal. In the context of the “Made in China 2025” Strategy, which, among others, sets out China’s goal of becoming a world leader in the field of life sciences and of reducing the country’s technological dependency, our article sets out to present the evolution of the Chinese investment policy over the recent years, which was focused on finding an optimum synergy between guiding foreign direct investment (FDI) in line with the country’s own sectoral modernisation plans, and targeting its own outward direct investment (ODI) in accordance with the same interests. With the U.S. being the global biotechnology leader and, as a result, China’s main competitor in the race for global supremacy in the field, our analysis will focus on highlighting the role and importance of bilateral China-U.S. investment flows for the development of the Chinese biotechnology sector.
ISSN:2343-9742
2343-9750